Literature DB >> 2451668

A membrane-anchored form but not the secretory form of human chorionic gonadotropin-alpha chain acquires polylactosaminoglycan.

M Fukuda1, J L Guan, J K Rose.   

Abstract

Large polylactosaminoglycans have only been observed linked to membrane proteins. To determine if membrane anchoring of a secretory protein might lead to the addition of polylactosaminoglycan, we have examined the carbohydrate structure on a membrane-anchored form of human chorionic gonadotropin-alpha subunit. This protein was generated by fusing the DNA encoding the human chorionic gonadotropin-alpha subunit to the DNA encoding the membrane-spanning and cytoplasmic domains of the vesicular stomatitis virus glycoprotein. DNAs encoding this hybrid form and the secretory form of human chorionic gonadotropin-alpha were expressed in monkey COS-1 cells using an SV40-based vector. We show here that the parent secretory glycoprotein contains typical Asn-linked complex-type oligosaccharides while the membrane-bound form contains large, heterogenous polylactosaminoglycans. We conclude that membrane anchoring increases the accessibility of the N-linked glycans to the enzymes involved in polylactosamine addition. The inhibitor 1-deoxymannojirimycin blocks addition of the polylactosaminoglycan.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451668

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Multiple glycoproteins synthesized by the smallest RNA segment (S10) of bluetongue virus.

Authors:  X Wu; S Y Chen; H Iwata; R W Compans; P Roy
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  Effect of lengthening lymphocyte function-associated antigen 3 on adhesion to CD2.

Authors:  P Y Chan; T A Springer
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

3.  The E1 glycoprotein of an avian coronavirus is targeted to the cis Golgi complex.

Authors:  C E Machamer; S A Mentone; J K Rose; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Effects of altered cytoplasmic domains on transport of the vesicular stomatitis virus glycoprotein are transferable to other proteins.

Authors:  J L Guan; A Ruusala; H Cao; J K Rose
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

5.  Site-specific glycosylation profile of influenza A (H1N1) hemagglutinin through tandem mass spectrometry.

Authors:  Esteban Cruz; Joel Cain; Ben Crossett; Veysel Kayser
Journal:  Hum Vaccin Immunother       Date:  2017-11-17       Impact factor: 3.452

6.  The structures of glycophorin C N-glycans, a putative component of the GPC receptor site for Plasmodium falciparum EBA-140 ligand.

Authors:  David J Ashline; Maria Duk; Jolanta Lukasiewicz; Vernon N Reinhold; Elwira Lisowska; Ewa Jaskiewicz
Journal:  Glycobiology       Date:  2014-12-30       Impact factor: 4.313

7.  Expression cloning of cDNA encoding a human beta-1,3-N-acetylglucosaminyltransferase that is essential for poly-N-acetyllactosamine synthesis.

Authors:  K Sasaki; K Kurata-Miura; M Ujita; K Angata; S Nakagawa; S Sekine; T Nishi; M Fukuda
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

8.  Aminosugar derivatives as potential anti-human immunodeficiency virus agents.

Authors:  A Karpas; G W Fleet; R A Dwek; S Petursson; S K Namgoong; N G Ramsden; G S Jacob; T W Rademacher
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  Isolation of a cDNA encoding a murine UDPgalactose:beta-D-galactosyl- 1,4-N-acetyl-D-glucosaminide alpha-1,3-galactosyltransferase: expression cloning by gene transfer.

Authors:  R D Larsen; V P Rajan; M M Ruff; J Kukowska-Latallo; R D Cummings; J B Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

10.  Structural proteins of equine arteritis virus.

Authors:  A A de Vries; E D Chirnside; M C Horzinek; P J Rottier
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.